Tagged with consultancy

Norway Erik W. Jakobsen of Norwegian consultancy Menon Economics gives an overview of the key dynamics at play in Norway’s economy today and the growing role that healthcare and the life sciences plays within it. Jakobsen touches on why Norway needs to become more competitive as a life sciences investment destination,…

China Jens Ewert, Life Science and Health Care Industry Leader at Deloitte China, shares his perspectives on the growth of China’s Life Sciences and Healthcare market, the strong presence of Deloitte within China as a consulting firm, the recent trends of the market and their commitment to delivering comprehensive solutions to…

Puerto Rico When life sciences companies decide to transfer the production of new drug to Puerto Rico, extend an existing production line, or simply sustain existing operations, they can count on the support of a vast network of service providers with unmatched expertise in quality and regulatory compliance, from premarket approval (PMA)…

China Mike Braun, partner at Deloitte China, shares his perspectives on the recent China reforms, the strong presence of Deloitte within China as a consulting firm with a DNA in professional services, the importance of the healthcare and life sciences industry to their business here, and their commitment to delivering comprehensive…

Puerto Rico Limaris Alvarado, business director of PharmaLex Puerto Rico (formerly ECHO Consulting Group), started ECHO Consulting Group to enhance and maintain the education of healthcare industry professionals in Puerto Rico via expert resources with international and regulatory experience. After 17 years, the company is a renowned leader of validation, quality and…

Korea The Pharmaceutical Strategy Institute (PSI) is a Korean consulting firm helping local biotech companies reach success by providing strategic and legal counsel all along the value chain. Its founder & CEO, Dr Jung Yun–Taek, explains the different services his company provides, his role in shaping government policies to foster the…

Korea Young Kim, founder and CEO of Synex Consulting Ltd., a consulting firm assisting healthcare companies in introducing and marketing their products on the Korean market, discusses how Synex’s ICC (In-Country Caretaker) service allows smaller firms to overcome regulatory barriers without having to set up an affiliate years prior to a…

Spain Antonio Lopez and Diego Monux, CEO and founding partner of SILO (Science and Innovation Link Office), talk about their niche offering of connecting both the public and private sector, in addition to discussing the opportunities for companies to capitalize on the scientific offering that Spain provides.   Most of our…

Malta Andrew Corrieri of Pharmaconsulta in Malta outlines his consultancy’s comprehensive service offering, the opportunities inherent in the Maltese life sciences industry and his plans for the future.   By overseeing the entire spectrum of regulatory affairs, we are able to act more efficiently and prevent any hiccups or delays that…

Malaysia Lee Yee Keng, head of healthcare sector of KPMG in Malaysia, highlights the opportunities Malaysia can offer to the healthcare industry, including its potential for private-public partnerships, and how the consultancy is positioning itself as the key partner for all companies in Malaysia and South-East Asia.   When it comes…

Spain Baltasar Lobato, managing partner of health and life sciences at EY Spain, highlights the major market trends affecting the public and private healthcare sector as well as the pharmaceutical market. He also gives an overview of the complex nature of the Spanish market, the importance of IT in creating a…

Spain Dr Sergi Trilla, CEO and founder of life sciences business development provider trifermed, introduces the company and explains its evolution to better serve the shifting paradigms of the healthcare and pharmaceutical sectors. He also offers his opinions on the critical position of the Spanish and European markets and how the…